Policy
Nasdaq Approves Listing of Canary’s Staked Injective ETF
The Defiant·November 4, 2026·1 min read
Nasdaq approved the listing of Canary's staked Injective ETF, which will stake at least 90% of its INJ holdings and charge a 1.10% annual sponsor fee. The fund, named INJC, marks a step toward staked crypto products in traditional markets.
Read at The DefiantDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.